News Daily News Routine IVUS in Peripheral Interventions Supported by Small RCT L.A. McKeown March 09, 2022
News Daily News Robert M. Califf Becomes 25th Commissioner of the US FDA L.A. McKeown February 15, 2022
News Daily News HawkOne Directional Atherectomy System Recalled Due to Risk of Tip Breakage L.A. McKeown January 21, 2022
News Daily News FDA Safety Communication Updates Stance on Endologix AAA Grafts L.A. McKeown January 13, 2022
News Daily News Statins Underprescribed in PAD Before and After Interventions L.A. McKeown December 03, 2021
News Daily News Intravascular Lithotripsy May Facilitate TAVI in Patients With PAD L.A. McKeown November 04, 2021
News Daily News FDA Issues New Guidance on Sodium Targets for Food Industry L.A. McKeown October 14, 2021
News Conference News VIVA 2021 EMINENT: Better Patency With DES Over BMS for Fem-Pop Lesions L.A. McKeown October 12, 2021
News Conference News VIVA 2021 Diverting or Swirling, New Blood-Flow Tech Shows Promise for CLTI L.A. McKeown October 08, 2021
News Conference News VIVA 2021 Striking Racial Gaps Exist in Care for Peripheral Interventions, Registry Affirms L.A. McKeown October 07, 2021
News Conference News VIVA 2021 Vascular Care Falls Short Before Amputation for CLI: Medicare Analysis L.A. McKeown October 06, 2021
News Daily News Rivaroxaban Safe, Effective in Renal Disease: VOYAGER PAD L.A. McKeown August 10, 2021
News Daily News COVID-19 Infection Boosts Acute MI, Stroke Risk in Early Weeks L.A. McKeown August 03, 2021
News Conference News ACC 2021 Rivaroxaban Helps Prevent More Events Than Aspirin Alone After Leg Interventions L.A. McKeown May 21, 2021